Just this March the FDA issued a Drug Safety Communication which was meant to alert
the public to a study which showed a correlation between Victoza, a drug for type-2
diabetes, to an increased risk of pancreatitis and pancreatic and thyroid cancers.
Victoza is in a group of drugs known as incretin mimetics which mimic GLP-1 (glucagon-like
peptide 1) which occurs naturally in the body. GLP-1 stimulates the pancreas, prompting
it to release insulin into the bloodstream. Cells are subsequently triggered to
absorb sugar from the bloodstream. Victoza is manufactured by Novo Nordisk. The
drug has also been found to slow the emptying of food from the stomach, resulting
in weight loss for many of those taking Victoza. In fact, Novo has stated their
goal of having Victoza approved for the treatment of obesity by 2014 despite the
growing number of adverse reports from those taking the drug.
What is Victoza and What are the Dangers?
Victoza is a once-daily drug which is administered via injection pen. It is important
to remember that Victoza is not insulin and some research has indicated that when
Victoza is used in combination with insulin or metformin, there may be an increased
risk of the patient developing hypoglycemia. Drugs which mimic GLP-1, like Victoza,
may cause increased inflammation in the pancreas which can lead to acute pancreatitis.
In turn, a history of pancreatitis can be a factor in the development of pancreatic
A study published in Diabetes in May, 2012, concluded that Victoza could be responsible
for stimulating the production of pre-cancerous cells which then may lead to pancreatic
cancer. Despite the fact that a consumer advocate group, Public Citizen, has called
for removal of Victoza from the American market, the manufacturer expects no action
from the FDA regarding Public Citizen’s allegations. Novo Nordisk brings in approximately
$350 million dollars per quarter from sales of Victoza alone, and continues to maintain
the drug has been properly tested and is safe.
Did Novo Nordisk Exhibit a Failure to Warn?
Novo even boasted that Victoza would give the type-2 diabetic drug Byetta serious
competition because Victoza is injected once per day rather than twice. At this
time the FDA stated they will review data from prior studies in order to investigate
the risk of pancreatic toxicity. The Public Citizen group notes that two FDA pharmacologists
and an FDA clinical safety reviewer advised against granting FDA approval for Victoza.
While there has not yet been a Victoza recall or a Victoza lawsuit (on its own),
many Victoza attorneys believe both of those are on the horizon. One lawsuit has
been filed against the manufacturers of Byetta, Januvia and Victoza on behalf of
Rosalie Duhon who took all three type-2 diabetic drugs. Duhon’s lawsuit was filed
on March 20, 2013 and alleged failure to warn, designing defective drugs, breach
of warranty, fraudulent concealment, negligence and negligent misrepresentation.
Duhon has stated publicly that had she known of the increased risk of pancreatic
cancer from the drugs she would not have consented to take any of them.
Getting the Help You Deserve for Victoza Injuries
Like Byetta and Januvia, it is likely that mass tort action and MDL’s as well as
individual Victoza lawsuits will be filed against Novo Nordisk in the future. Those
who have suffered significant harm from taking Victoza will want to seek compensation
from Novo for their medical expenses as well as possibly for lost wages and pain
and suffering. Of course the likelihood of winning a lawsuit against Novo Nordisk
is not absolute and will depend on the facts of the case. The attorneys of Sullo
& Sullo are both qualified and experienced and would be glad to hear the facts of
Our attorneys will then do a comprehensive evaluation and determine whether you
do, in fact, have a solid case against Novo. Obviously those who have been harmed
the most will have a better claim, but it is in your best interests to speak with
a Sullo & Sullo attorney to receive an experienced assessment. A Victoza lawyer
from the firm of Sullo & Sullo will have compassion for the harm you have suffered
and will ensure you receive zealous representation for the harm suffered from a
drug you believed to be safe.
After all, if all members of the FDA were not completely sold on the safety of the
drug, then it stands to reason that Novo had at least some indication that Victoza
could potentially cause negative health effects in some patients. Our Sullo & Sullo
attorneys have worked with product liability cases and understand the ins and outs
of this type of case as well as the statute of limitations which exists for these
cases. Call Sullo & Sullo today to speak to a knowledgeable attorney regarding your
serious Victoza side effects and a possible Victoza lawsuit.